$28M Philly Xarelto Verdict Ripe For Reversal, Attys Say

Law360, Philadelphia (December 6, 2017, 6:27 PM EST) -- After three prior bellwether trial losses, plaintiffs in litigation over the anticoagulant Xarelto are hoping to gain momentum following a $27.8 million verdict in Philadelphia on Tuesday, but attorneys say the award faces an uncertain future thanks to testimony that additional warnings would not have changed a doctor's decision to prescribe the drug.

The verdict against a pair of Johnson & Johnson and Bayer AG units, which included $26 million in punitive damages, came despite testimony from plaintiff Lynn Hartman's physician that additional warnings about the...
To view the full article, register now.